Faculty profile

David Collister

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

David Collister

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
69 publications in the last five years, latest in 2026.
Senior (last) author on 15 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

897

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Transgender Cardiovascular Gender-Affirming Hormone Therapy Kidney Quality Of Life Biomarkers Chronic Kidney Disease Estimated Glomerular Fiiltration Rate

Latest papers

Global landscape of kidney health across Indigenous populations
Nature Reviews Nephrology · 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
Journal of the American Medical Association (JAMA) · 2026
Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol
Canadian Journal of Kidney Health and Disease · 2026

All 70 publications

Latest funding

Life Participation, Kidney Function, and Cardiovascular Health in Transgender and Non-Binary Individuals Receiving Gender-Affirming Hormone Therapy
CIHR · 2026 · Principal investigator
$700,000
Prevent and Treat Diabetes for Healthy Living in Indigenous Communities of Alberta (Prev-Treat)
CIHR · 2024 · Co-investigator
$734,400
Advancing Gender Inclusive and Equitable Research with Research Ethics Boards
CIHR · 2024 · Co-investigator
$50,000

All 8 grants and awards

70 publications.

Global landscape of kidney health across Indigenous populations

Tungsanga S, Okpechi IG, Bianchi MEV, Chaturvedi S, Collister D, Crowshoe H, Rodriguez de Sosa GM, Galadanci HA, Hedin E, Ibrahim KS

Nature Reviews Nephrology202610 citations

DOI: 10.1038/s41581-025-01016-2

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Badve SV, Perkovic V, Jha V, Ramachandran R, Mushahar L, Menne J, De Vriese AS, Rossignol P, Flahault A, Al Ammari M

Journal of the American Medical Association (JAMA)20265 citations

DOI: 10.1001/jama.2026.9379

Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol

Bennett PN, Penny JD, McIntyre CW, Vanderlinden J, Borkum MS, Castillo G, Collister D, Corradetti B, Duhamel TA, Farion H

Canadian Journal of Kidney Health and Disease20262 citations

DOI: 10.1177/20543581251391112

Participant diversity and inclusive trial design: a meta-epidemiologic study of Canadian randomized clinical trials

Ruzycki SM, Lithgow KC, Song C, Taylor S, Subramanian A, Li M, Happ S, Shea M, Oladimeji D, Clark W

Journal of Clinical Epidemiology20262 citationsSenior author

DOI: 10.1016/j.jclinepi.2025.112098

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

Badve SV, Al Ammari M, Anderson CS, Billot L, Bompoint S, Collister D, De Vriese AS, Eikelboom JW, Flahault A, Garg AX

American Journal of Nephrology20261 citations

DOI: 10.1159/000550796

Sex Differences in Associations Between Measures of Hemodialysis Adequacy and Quality, Cardiovascular Outcomes, and Mortality: A Systematic Review

Riehl-Tonn VJ, Nicholl DDM, Ronksley PE, MacRae JM, Dumanski SM, Elliott MJ, Norris CM, Collister D, Ganshorn H, Ahmed SB

Kidney Medicine20261 citations

DOI: 10.1016/j.xkme.2026.101246

Representation of Older Patients Receiving Maintenance Dialysis in Randomized Controlled Trials: A Meta-epidemiologic Study

Wang K, Bamber Z, Pyne L, Bhasin AA, Walsh M, Krishnasamy R, Chertow GM, Pecoits-Filho R, Klarenbach S, Thompson S

American Journal of Kidney Diseases2026Senior author

DOI: 10.1053/j.ajkd.2025.09.023

Integrated, Community-Led, Culturally Safe Implementation of a Chronic Kidney Disease Detection Program for Indigenous Communities of Canada: The Kidney Check Program Report

Tungsanga S, Woods C, Allu S, Dart AB, Jain AK, Jorgensen L, Hampson M, Harasemiw O, Hébert M, Kappel J

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261447194

A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease

Saini R, More K, Wilson J-AS, Clark DA, Vinson AJ, Collister D, Canney M, Tennankore KK

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261437775

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

Walsh M, Collister D, Gallagher M, Mark PB, de Zoysa JR, Tyrwhitt J, Tennankore K, Reis G, Xavier D, Liu WJ

The Lancet202544 citations

DOI: 10.1016/s0140-6736(25)01198-5

Something wrong or missing on this profile? Suggest a correction

David Collister

Research

Latest papers

Latest funding

Global landscape of kidney health across Indigenous populations

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol

Participant diversity and inclusive trial design: a meta-epidemiologic study of Canadian randomized clinical trials

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

Sex Differences in Associations Between Measures of Hemodialysis Adequacy and Quality, Cardiovascular Outcomes, and Mortality: A Systematic Review

Representation of Older Patients Receiving Maintenance Dialysis in Randomized Controlled Trials: A Meta-epidemiologic Study

Integrated, Community-Led, Culturally Safe Implementation of a Chronic Kidney Disease Detection Program for Indigenous Communities of Canada: The Kidney Check Program Report

A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

Frequent collaborators

David Collister

David Collister

Michael Walsh

Navdeep Tangri

Clara Bohm

Claudio Rigatto

Paul Komenda

Karthik Tennankore

Murdoch Leeies

Stephanie Thompson

Neesh Pannu

Julie Ho

Scott Klarenbach

Adeera Levin

Murdoch Leeies

Somkanya Tungsanga

Sonny Dhanani

Lonnie Pyne

Ron Wald

Aminu Bello

Amit Garg

Braden Manns

Philip Devereaux

Darren Lau

Elissa Rennert-May

Sofia Ahmed

Sonny Dhanani

Raynell Lang

Jennifer Macrae

Raynell Lang

Zack Marshall

Maureena Loth

Christine White

Emery Potter

Jenine Leal

Ayodele Odutayo